Answers are grounded in this paper and cite their sources.
DNA double-strand breaks (DSBs) are highly cytotoxic lesions repaired primarily by homologous recombination (HR) and non-homologous end joining (NHEJ), with alternative end joining (alt-EJ) and single-strand annealing (SSA) functioning as backup. Repair pathway choice is governed by DNA end resection, suppressing NHEJ and committing repair to homology-based processes. Using pharmacological inhibition and protein depletion approaches in irradiated human cells, we show that PLK1 alone controls resection in S-phase-irradiated cells, while PLK1 and PLK3 act redundantly in G 2 -phase-irradiated cells. This cell-cycle-dependent regulation operates through a mechanism distinct from SCF SKP2 -APC/C CDH1 -mediated CtIP level modulation. These findings establish PLK1 and PLK3 as cell-cycle-dependent regulators of DSB repair pathway choice, advancing our understanding of how cell-cycle progression is coupled to repair decisions through differential PLK activity.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: